Will Trump's plan lower drug prices?
October 11, 2018 | Hagop M. Kantarjian, Vivian Ho

Table of Contents
Author(s)
Hagop M. Kantarjian
Nonresident Fellow in Health PolicyVivian Ho
James A. Baker III Institute Chair in Health EconomicsBy Hagop Kantarjian, Donald W. Light and Vivian Ho
The authors assess the Trump administration's plan to bring down drug prices and its potential implications for the cost of cancer drugs. American Journal of Hematology (subscription required): http://bit.ly/2QM0yZf.